首页 > 最新文献

Health Care Law & Policy eJournal最新文献

英文 中文
The Role of Charity in a Federal System 慈善在联邦制中的作用
Pub Date : 2011-03-02 DOI: 10.2139/ssrn.1473107
Brian Galle
This Article critiques the prevailing justification for subsidies for the charitable sector, and suggests a new alternative. According to contemporary accounts, charity corrects the failure of the private market to provide public goods, and further corrects the failure of government to provide goods other than those demanded by the median voter.However, the claim that government can meet the needs only of a single “median voter” neglects both federalism and public choice theory. Citizens dissatisfied with the services of one government can move to or even create another. Alternatively, they may use the threat of exit to lobby for local change. Subsidies for charity inefficiently distort the operation of these markets for legal rules.Nonetheless, there remains a strong case for subsidizing charity, albeit on grounds new to the literature. Charity serves as gap-filler when federalism mechanisms break down. For example, frictions on exit produce too little jurisdictional competition, and excessively easy exit produces too much competition - a race to the bottom. At the same time, competition from government constrains inefficient charities. Thus, charity and government each perform best as complements to the other.Finally, this Article sketches the normative legal consequences of these claims. Most significantly, I respond to the claims by Malani and Posner that for-profit charity would be superior to current arrangements. That suggestion would fatally weaken competition between charity and government, defeating the only persuasive purpose for charitable subsidies.
本文对慈善部门补贴的现行理由进行了批判,并提出了一种新的替代方案。根据当代的说法,慈善纠正了私人市场提供公共产品的失败,并进一步纠正了政府提供非中间选民所需产品的失败。然而,政府只能满足一个“中间选民”的需求的说法忽视了联邦制和公共选择理论。对一个政府的服务不满的公民可以转移到甚至创建另一个政府。或者,他们可能会利用退出的威胁来游说当地的变革。慈善补贴无效地扭曲了这些法律规则市场的运作。尽管如此,对慈善机构进行补贴仍然是一个强有力的理由,尽管是基于新的文献。当联邦制机制崩溃时,慈善机构充当了填补空缺的角色。例如,退出方面的摩擦导致管辖权竞争过少,而过于容易的退出又导致竞争过多——一种逐底竞争。与此同时,来自政府的竞争限制了效率低下的慈善机构。因此,慈善和政府互为补充,各自表现最好。最后,本文概述了这些主张的规范性法律后果。最重要的是,我回应了马拉尼和波斯纳的主张,即营利性慈善机构将优于目前的安排。这一建议将致命地削弱慈善机构与政府之间的竞争,破坏慈善补贴唯一具有说服力的目的。
{"title":"The Role of Charity in a Federal System","authors":"Brian Galle","doi":"10.2139/ssrn.1473107","DOIUrl":"https://doi.org/10.2139/ssrn.1473107","url":null,"abstract":"This Article critiques the prevailing justification for subsidies for the charitable sector, and suggests a new alternative. According to contemporary accounts, charity corrects the failure of the private market to provide public goods, and further corrects the failure of government to provide goods other than those demanded by the median voter.However, the claim that government can meet the needs only of a single “median voter” neglects both federalism and public choice theory. Citizens dissatisfied with the services of one government can move to or even create another. Alternatively, they may use the threat of exit to lobby for local change. Subsidies for charity inefficiently distort the operation of these markets for legal rules.Nonetheless, there remains a strong case for subsidizing charity, albeit on grounds new to the literature. Charity serves as gap-filler when federalism mechanisms break down. For example, frictions on exit produce too little jurisdictional competition, and excessively easy exit produces too much competition - a race to the bottom. At the same time, competition from government constrains inefficient charities. Thus, charity and government each perform best as complements to the other.Finally, this Article sketches the normative legal consequences of these claims. Most significantly, I respond to the claims by Malani and Posner that for-profit charity would be superior to current arrangements. That suggestion would fatally weaken competition between charity and government, defeating the only persuasive purpose for charitable subsidies.","PeriodicalId":230649,"journal":{"name":"Health Care Law & Policy eJournal","volume":"35 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2011-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133111830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Anti-Competitive Strategies Hamper Access to Medicines in Europe 反竞争战略阻碍了欧洲药品的获取
Pub Date : 2011-02-02 DOI: 10.37974/alf.165
K. Perehudoff, Sophie Bloemen
An unprecedented number of Europeans are living longer. In the next decade, most 'baby boomers' will retire from the workforce. Meanwhile, the birth rate in Europe continues to fall and, as a result, there will be fewer people to contribute to social security systems, jeopardising the financial support base for our health insurance. Seniority brings new health challenges, often in the form of age-related and/or chronic diseases, requiring long-term medical interventions. European governments are eyeing their pharmaceutical expenditure to cut costs, while expensive brand or originator medicines compound health care bills. Some patients and consumers, particularly those in Eastern Europe, pay out-of-pocket expenses for the medicines they are prescribed. This disparity raises questions about equitable access across the European Union. Because of their integral importance to our health and wellbeing, essential medicines need to be affordable and accessible for all European consumers in spite of cuts to social services and health budgets. This article examines how governments could guarantee access to high quality, safe and effective medicines in the face of Europe's aging population, changing health needs and rising pharmaceutical expenses.
欧洲人寿命延长的人数前所未有。在未来十年,大多数“婴儿潮一代”将退出劳动力市场。与此同时,欧洲的出生率继续下降,因此,向社会保障体系缴费的人数将减少,危及我们医疗保险的财政支持基础。资历带来新的健康挑战,往往表现为与年龄有关的疾病和/或慢性病,需要长期的医疗干预。欧洲各国政府正密切关注自己的医药支出,以削减成本,而昂贵的品牌或原创药品加剧了医疗保健账单。一些病人和消费者,特别是东欧的病人和消费者,为他们开的药支付自付费用。这种差异引发了关于整个欧盟公平准入的问题。由于基本药物对我们的健康和福祉具有不可或缺的重要性,尽管削减了社会服务和卫生预算,但所有欧洲消费者都需要负担得起并能够获得基本药物。本文探讨了面对欧洲人口老龄化、不断变化的健康需求和不断上升的医药费用,政府如何保证获得高质量、安全和有效的药品。
{"title":"Anti-Competitive Strategies Hamper Access to Medicines in Europe","authors":"K. Perehudoff, Sophie Bloemen","doi":"10.37974/alf.165","DOIUrl":"https://doi.org/10.37974/alf.165","url":null,"abstract":"An unprecedented number of Europeans are living longer. In the next decade, most 'baby boomers' will retire from the workforce. Meanwhile, the birth rate in Europe continues to fall and, as a result, there will be fewer people to contribute to social security systems, jeopardising the financial support base for our health insurance. Seniority brings new health challenges, often in the form of age-related and/or chronic diseases, requiring long-term medical interventions. European governments are eyeing their pharmaceutical expenditure to cut costs, while expensive brand or originator medicines compound health care bills. Some patients and consumers, particularly those in Eastern Europe, pay out-of-pocket expenses for the medicines they are prescribed. This disparity raises questions about equitable access across the European Union. Because of their integral importance to our health and wellbeing, essential medicines need to be affordable and accessible for all European consumers in spite of cuts to social services and health budgets. This article examines how governments could guarantee access to high quality, safe and effective medicines in the face of Europe's aging population, changing health needs and rising pharmaceutical expenses.","PeriodicalId":230649,"journal":{"name":"Health Care Law & Policy eJournal","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2011-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129187574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Of Minors and the Mentally Ill: Re-Positioning Perspectives on Consent to Health Care 未成年人和精神病患者:对医疗保健同意的重新定位观点
Pub Date : 2011-02-01 DOI: 10.22329/WYAJ.V29I0.4482
Mona Paré
Recognition of people's right to consent to health care is linked to legal capacity and to respect for physical and mental integrity. Traditionally, children and persons with mental illness have been denied this right and substitute decision-making systems have been used for their protection. Today, respect for rights and freedoms forces courts and legislators to find a balance between autonomy and protection. However, domestic law lacks vision and objectives, often ending up breaching both protection and autonomy rights, or prioritizing one to the detriment of the other. One should turn to the supported decision-making model, which addresses protection concerns while respecting people's integrity and autonomy.
承认人民同意保健的权利与法律行为能力和尊重身心健全有关。传统上,儿童和精神疾病患者被剥夺了这项权利,并使用替代决策制度来保护他们。今天,对权利和自由的尊重迫使法院和立法者在自治和保护之间找到平衡。然而,国内法缺乏远见和目标,往往最终违反了保护权和自治权,或者优先考虑其中一项而损害另一项。应该转向辅助决策模式,在尊重人的完整性和自主权的同时解决保护问题。
{"title":"Of Minors and the Mentally Ill: Re-Positioning Perspectives on Consent to Health Care","authors":"Mona Paré","doi":"10.22329/WYAJ.V29I0.4482","DOIUrl":"https://doi.org/10.22329/WYAJ.V29I0.4482","url":null,"abstract":"Recognition of people's right to consent to health care is linked to legal capacity and to respect for physical and mental integrity. Traditionally, children and persons with mental illness have been denied this right and substitute decision-making systems have been used for their protection. Today, respect for rights and freedoms forces courts and legislators to find a balance between autonomy and protection. However, domestic law lacks vision and objectives, often ending up breaching both protection and autonomy rights, or prioritizing one to the detriment of the other. One should turn to the supported decision-making model, which addresses protection concerns while respecting people's integrity and autonomy.","PeriodicalId":230649,"journal":{"name":"Health Care Law & Policy eJournal","volume":"13 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2011-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114173229","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
The Effect of Competition on Process and Outcome Quality within Hospital Care in the Netherlands 竞争对荷兰医院护理过程和结果质量的影响
Pub Date : 2011-01-12 DOI: 10.2139/ssrn.1738924
M. Bijlsma, P. Koning, V. Shestalova
This study examines the impact of competition on hospital quality. Our panel covers all Dutch hospitals in the period 2004–2008, in which the transparency of hospital quality information increased substantially. The paper contributes to the existing literature by including both outcome and process indicators of quality. We find that competition explains the cross-sectional differences in process indicators, but not in outcome indicators. In particular, more competition in the hospital’s catchment area leads to more operation cancellations at short notice and more delays of hip fracture injury operations for elderly patients. Both results suggest that competition increases the utilization of operation capacity. At the same time, hospitals that face more competition perform check-ups for chronic patients more frequently and organize diagnostic processes more efficiently.
本研究探讨竞争对医院品质的影响。我们的小组涵盖了2004-2008年期间所有荷兰医院,在此期间,医院质量信息的透明度大大提高。本文通过包括结果和过程质量指标对现有文献做出贡献。我们发现竞争可以解释过程指标的横截面差异,但不能解释结果指标的横截面差异。特别是医院接诊区域的竞争加剧,导致更多的手术在短时间内取消,更多的老年患者髋部骨折损伤手术延误。这两个结果都表明竞争提高了运营能力的利用率。与此同时,面临更多竞争的医院更频繁地为慢性病患者进行检查,并更有效地组织诊断过程。
{"title":"The Effect of Competition on Process and Outcome Quality within Hospital Care in the Netherlands","authors":"M. Bijlsma, P. Koning, V. Shestalova","doi":"10.2139/ssrn.1738924","DOIUrl":"https://doi.org/10.2139/ssrn.1738924","url":null,"abstract":"This study examines the impact of competition on hospital quality. Our panel covers all Dutch hospitals in the period 2004–2008, in which the transparency of hospital quality information increased substantially. The paper contributes to the existing literature by including both outcome and process indicators of quality. We find that competition explains the cross-sectional differences in process indicators, but not in outcome indicators. In particular, more competition in the hospital’s catchment area leads to more operation cancellations at short notice and more delays of hip fracture injury operations for elderly patients. Both results suggest that competition increases the utilization of operation capacity. At the same time, hospitals that face more competition perform check-ups for chronic patients more frequently and organize diagnostic processes more efficiently.","PeriodicalId":230649,"journal":{"name":"Health Care Law & Policy eJournal","volume":"4 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2011-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130107871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
The Private Action Requirement 私人诉讼要求
Pub Date : 2010-12-16 DOI: 10.25148/LAWREV.6.1.4
Gerard N. Magliocca
This Symposium Essay assesses the constitutional challenge to the individual health insurance mandate. The principal argument against the mandate is that Congress is barred from regulating private inaction (or compelling action) under its Commerce Clause authority. Such a "private action" requirement must be judged by comparison to the state action doctrine of the Fourteenth Amendment, which is the only other general limitation on the power of Congress that distinguishes between acts and omissions. Measured against this principle, the attack on the individual mandate is without merit.
这篇专题讨论会论文评估了对个人健康保险授权的宪法挑战。反对强制令的主要论点是,国会被禁止在其商业条款授权下监管私人不作为(或强制行动)。这种“私人行为”要求必须通过与第十四修正案的国家行为原则进行比较来判断,这是对国会权力区分作为与不作为的唯一一般限制。根据这一原则来衡量,对个人强制医保的攻击是没有道理的。
{"title":"The Private Action Requirement","authors":"Gerard N. Magliocca","doi":"10.25148/LAWREV.6.1.4","DOIUrl":"https://doi.org/10.25148/LAWREV.6.1.4","url":null,"abstract":"This Symposium Essay assesses the constitutional challenge to the individual health insurance mandate. The principal argument against the mandate is that Congress is barred from regulating private inaction (or compelling action) under its Commerce Clause authority. Such a \"private action\" requirement must be judged by comparison to the state action doctrine of the Fourteenth Amendment, which is the only other general limitation on the power of Congress that distinguishes between acts and omissions. Measured against this principle, the attack on the individual mandate is without merit.","PeriodicalId":230649,"journal":{"name":"Health Care Law & Policy eJournal","volume":"8 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2010-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124173935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Limits of Disclosure as a Response to Financial Conflicts of Interest in Clinical Research 临床研究财务利益冲突中披露的局限性
Pub Date : 2010-12-05 DOI: 10.2139/SSRN.1720564
K. Boozang, C. Coleman, Kate Greenwood, Simone Handler-Hutchinson, C. Finizio
While allowing that transparency should be one of the tools employed to manage clinical researchers' conflicts of interest, this paper disagrees with the numerous recommendations that such information become part of the informed consent process. Empirical research in several areas suggests that the provision of this information to prospective trial participants will too often cause information overload; further, few research participants understand the relevance of the information to them once provided. Because many clinical trial participants do not have viable alternatives to trial participation, the information is not facilitating exit from participation. In short, we conclude that embedding this complicated information will ultimately do more harm than good for most recipients.
虽然允许透明度应该是用来管理临床研究人员利益冲突的工具之一,但本文不同意将此类信息作为知情同意过程一部分的众多建议。几个领域的实证研究表明,向潜在试验参与者提供这些信息往往会导致信息过载;此外,很少有研究参与者理解一旦提供给他们的信息的相关性。由于许多临床试验参与者没有可行的替代方案参与试验,因此该信息无法促进退出参与。简而言之,我们得出结论,对大多数接受者来说,嵌入这些复杂的信息最终弊大于利。
{"title":"The Limits of Disclosure as a Response to Financial Conflicts of Interest in Clinical Research","authors":"K. Boozang, C. Coleman, Kate Greenwood, Simone Handler-Hutchinson, C. Finizio","doi":"10.2139/SSRN.1720564","DOIUrl":"https://doi.org/10.2139/SSRN.1720564","url":null,"abstract":"While allowing that transparency should be one of the tools employed to manage clinical researchers' conflicts of interest, this paper disagrees with the numerous recommendations that such information become part of the informed consent process. Empirical research in several areas suggests that the provision of this information to prospective trial participants will too often cause information overload; further, few research participants understand the relevance of the information to them once provided. Because many clinical trial participants do not have viable alternatives to trial participation, the information is not facilitating exit from participation. In short, we conclude that embedding this complicated information will ultimately do more harm than good for most recipients.","PeriodicalId":230649,"journal":{"name":"Health Care Law & Policy eJournal","volume":"35 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2010-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127695996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Tort Liability and the Market for Prescription Drugs 侵权责任与处方药市场
Pub Date : 2010-06-03 DOI: 10.2139/ssrn.1641239
Eric A. Helland, D. Lakdawalla, S. Seabury, A. Malani
Nearly all the empirical literature on tort liability in the healthcare sector focuses on physicians. Yet both drug companies and physicians lose roughly the same portion of revenue (2 percent) to liability expenses.Moreover, the health care system’s expenditures on drugs are rising nearly twice as fast as expenditures on physician and hospital care. In this paper we model and estimate the welfare effects of failure‐to‐warn suits, the most common type of tort litigation involving drug companies. We find that tort liability ‐‐ proxied by punitive damage caps ‐‐ increases drug prices but that it also reduces side effects. Moreover, we find that tort liability increases the equilibrium quantity of drug sales. This suggests that liability not only increases cost and reduces supply, but also increases expected safety and thus demand. Together the increase in equilibrium quantity and reduction in side effects suggests that tort liability improves social welfare.
几乎所有关于医疗保健部门侵权责任的实证文献都集中在医生身上。然而,制药公司和医生因责任费用而损失的收入比例大致相同(2%)。此外,医疗保健系统的药品支出增长速度几乎是医生和医院护理支出的两倍。在本文中,我们建立模型并估计了未预警诉讼的福利效应,这是涉及制药公司的最常见的侵权诉讼类型。我们发现,由惩罚性损害赔偿上限所代表的侵权责任增加了药品价格,但也减少了副作用。此外,我们发现侵权责任增加了药品销售的均衡数量。这表明,责任不仅增加了成本,减少了供应,而且增加了预期安全性,从而增加了需求。均衡数量的增加和副作用的减少共同表明,侵权责任改善了社会福利。
{"title":"Tort Liability and the Market for Prescription Drugs","authors":"Eric A. Helland, D. Lakdawalla, S. Seabury, A. Malani","doi":"10.2139/ssrn.1641239","DOIUrl":"https://doi.org/10.2139/ssrn.1641239","url":null,"abstract":"Nearly all the empirical literature on tort liability in the healthcare sector focuses on physicians. Yet both drug companies and physicians lose roughly the same portion of revenue (2 percent) to liability expenses.Moreover, the health care system’s expenditures on drugs are rising nearly twice as fast as expenditures on physician and hospital care. In this paper we model and estimate the welfare effects of failure‐to‐warn suits, the most common type of tort litigation involving drug companies. We find that tort liability ‐‐ proxied by punitive damage caps ‐‐ increases drug prices but that it also reduces side effects. Moreover, we find that tort liability increases the equilibrium quantity of drug sales. This suggests that liability not only increases cost and reduces supply, but also increases expected safety and thus demand. Together the increase in equilibrium quantity and reduction in side effects suggests that tort liability improves social welfare.","PeriodicalId":230649,"journal":{"name":"Health Care Law & Policy eJournal","volume":"80 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2010-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123404726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Health Insurance Coverage Among Youth and Young Adults with Work Limitations 有工作限制的青年和青壮年的健康保险覆盖面
Pub Date : 2007-05-08 DOI: 10.2139/SSRN.984232
Bonnie O'day, D. Stapleton, Ann E. Horvath-Rose
This paper explores health insurance coverage trends for youth (age 15-18) and young adults (age 19-29) with work limitations using data from the Current Population Survey. In 2000 those in the young work-limited population were substantially more likely to have insurance coverage than their counterparts in the not work-limited population. They were much more likely to have public coverage and much less likely to have only private coverage. Insurance coverage for this population increased substantially between 1989 and 2000, in contrast to a decline for the not work-limited population. We discuss the probable contributions of policy reforms and the decline in employment of people with work limitations to these trends.
本文利用当前人口调查的数据,探讨了有工作限制的青年(15-18岁)和年轻人(19-29岁)的健康保险覆盖趋势。2000年,工作受限的年轻人比工作不受限的年轻人更有可能获得保险。他们更有可能有公共保险而不太可能只有私人保险。1989年至2000年期间,这类人口的保险覆盖率大幅增加,而非工作有限人口的保险覆盖率则有所下降。我们讨论了政策改革和有工作限制的人就业率下降对这些趋势的可能贡献。
{"title":"Health Insurance Coverage Among Youth and Young Adults with Work Limitations","authors":"Bonnie O'day, D. Stapleton, Ann E. Horvath-Rose","doi":"10.2139/SSRN.984232","DOIUrl":"https://doi.org/10.2139/SSRN.984232","url":null,"abstract":"This paper explores health insurance coverage trends for youth (age 15-18) and young adults (age 19-29) with work limitations using data from the Current Population Survey. In 2000 those in the young work-limited population were substantially more likely to have insurance coverage than their counterparts in the not work-limited population. They were much more likely to have public coverage and much less likely to have only private coverage. Insurance coverage for this population increased substantially between 1989 and 2000, in contrast to a decline for the not work-limited population. We discuss the probable contributions of policy reforms and the decline in employment of people with work limitations to these trends.","PeriodicalId":230649,"journal":{"name":"Health Care Law & Policy eJournal","volume":"108 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2007-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115070236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Crowd-Out Ten Years Later: Have Recent Public Insurance Expansions Crowded Out Private Health Insurance? 十年后的挤占:最近公共保险的扩张是否挤占了私人医疗保险?
Pub Date : 2007-01-01 DOI: 10.3386/w12858
J. Gruber, K. Simon
The continued interest in public insurance expansions as a means of covering the uninsured highlights the importance of estimates of "crowd-out", or the extent to which such expansions reduce private insurance coverage. Ten years ago, Cutler and Gruber (1996) suggested that such crowd-out might be quite large, but much subsequent research has questioned this conclusion. We revisit this issue by using improved data and incorporating the research approaches that have led to varying estimates. We focus in particular on the public insurance expansions of the 1996-2002 period. Our results clearly show that crowd-out is significant; the central tendency in our results is a crowd-out rate of about 60%. This finding emerges most strongly when we consider family-level measures of public insurance eligibility. We also find that recent anti-crowd-out provisions in public expansions may have had the opposite effect, lowering take-up by the uninsured faster than they lower crowd-out of private insurance.
对公共保险扩张作为覆盖未参保人群的一种手段的持续关注,突显了“挤出”估计的重要性,或者说这种扩张在多大程度上减少了私人保险的覆盖范围。十年前,Cutler和Gruber(1996)提出这种挤出可能相当大,但随后的许多研究对这一结论提出了质疑。我们通过使用改进的数据并结合导致不同估计的研究方法来重新审视这个问题。我们特别关注1996-2002年期间公共保险的扩张。我们的结果清楚地表明,拥挤是显著的;我们的结果的集中趋势是大约60%的挤出率。当我们考虑公共保险资格的家庭层面衡量标准时,这一发现最为明显。我们还发现,最近公共扩张中的反挤占条款可能产生了相反的效果,降低未参保者的参保率比降低私人保险的挤占率更快。
{"title":"Crowd-Out Ten Years Later: Have Recent Public Insurance Expansions Crowded Out Private Health Insurance?","authors":"J. Gruber, K. Simon","doi":"10.3386/w12858","DOIUrl":"https://doi.org/10.3386/w12858","url":null,"abstract":"The continued interest in public insurance expansions as a means of covering the uninsured highlights the importance of estimates of \"crowd-out\", or the extent to which such expansions reduce private insurance coverage. Ten years ago, Cutler and Gruber (1996) suggested that such crowd-out might be quite large, but much subsequent research has questioned this conclusion. We revisit this issue by using improved data and incorporating the research approaches that have led to varying estimates. We focus in particular on the public insurance expansions of the 1996-2002 period. Our results clearly show that crowd-out is significant; the central tendency in our results is a crowd-out rate of about 60%. This finding emerges most strongly when we consider family-level measures of public insurance eligibility. We also find that recent anti-crowd-out provisions in public expansions may have had the opposite effect, lowering take-up by the uninsured faster than they lower crowd-out of private insurance.","PeriodicalId":230649,"journal":{"name":"Health Care Law & Policy eJournal","volume":"28 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2007-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127817589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 69
Universal Immunization Programme in India: The Determinants of Childhood Immunization 印度普遍免疫规划:儿童免疫的决定因素
Pub Date : 2006-02-07 DOI: 10.2139/SSRN.881224
Nilanjan Patra
The study analyses the effects of some selected demographic and socioeconomic predictor variables on likelihood of immunization of a child for six vaccine-preventable diseases covered under UIP. It focuses on immunization coverage a) in all India, b) in rural and urban areas, c) for DPT, Polio, and partial immunization, d) for three groups of states, namely, Empowered Action Group, North-Eastern and other states, and e) for three states, namely, Bihar, Tamilnadu, and West Bengal. The study applies logistic regression model to National Family Health Survey-2 (1998-99) data. Excepting a few cases, the results are consistent across different models. Likelihood increases with residence, mother's education level, mother's exposure to mass media, mother's awareness about immunization, antenatal care during pregnancy, standard of living index of household, electricity, female household-headship, mother's empowerment index, and sex of the child; it decreases with birth-order irrespective of the sex of the child. Religion, caste/tribe and zone of states also have some effects. Further research with both demand- and supply-side issues and current data will be critical for the policy makers to make the immunization programme justly universal.
该研究分析了一些选定的人口和社会经济预测变量对儿童接种统一免疫计划涵盖的六种疫苗可预防疾病的可能性的影响。它的重点是免疫接种覆盖:a)印度全国;b)农村和城市地区;c)百白破、脊髓灰质炎和部分免疫接种;d)三组邦,即赋权行动组、东北邦和其他邦;e)三个邦,即比哈尔邦、泰米尔纳德邦和西孟加拉邦。本研究采用logistic回归模型对全国家庭健康调查-2(1998-99)数据进行分析。除了少数情况外,不同模型的结果是一致的。可能性随居住地、母亲受教育程度、母亲接触大众媒体、母亲对免疫接种的认识、怀孕期间的产前保健、家庭生活水平指数、电力、女性户主、母亲赋权指数和儿童性别而增加;它随着出生顺序而减少,与孩子的性别无关。宗教、种姓/部落和邦的区域也有一些影响。进一步研究需求和供给方面的问题以及目前的数据对于决策者使免疫规划公正地普及至关重要。
{"title":"Universal Immunization Programme in India: The Determinants of Childhood Immunization","authors":"Nilanjan Patra","doi":"10.2139/SSRN.881224","DOIUrl":"https://doi.org/10.2139/SSRN.881224","url":null,"abstract":"The study analyses the effects of some selected demographic and socioeconomic predictor variables on likelihood of immunization of a child for six vaccine-preventable diseases covered under UIP. It focuses on immunization coverage a) in all India, b) in rural and urban areas, c) for DPT, Polio, and partial immunization, d) for three groups of states, namely, Empowered Action Group, North-Eastern and other states, and e) for three states, namely, Bihar, Tamilnadu, and West Bengal. The study applies logistic regression model to National Family Health Survey-2 (1998-99) data. Excepting a few cases, the results are consistent across different models. Likelihood increases with residence, mother's education level, mother's exposure to mass media, mother's awareness about immunization, antenatal care during pregnancy, standard of living index of household, electricity, female household-headship, mother's empowerment index, and sex of the child; it decreases with birth-order irrespective of the sex of the child. Religion, caste/tribe and zone of states also have some effects. Further research with both demand- and supply-side issues and current data will be critical for the policy makers to make the immunization programme justly universal.","PeriodicalId":230649,"journal":{"name":"Health Care Law & Policy eJournal","volume":"124 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2006-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116379355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 33
期刊
Health Care Law & Policy eJournal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1